Dr. Chris Kryder

Dr. Chris Kryder is a leader in the healthcare information technology arena with decades of experience as an operator of, and investor in, healthcare information technology firms. In addition to serving as Executive Chairman for Higi, Dr. Kryder is an Executive Partner in Boston-based Flare Capital Partners, and serves on the boards of several HCIT firms.

Most recently, Dr. Kryder served as Chairman of Valence Health from 2012-2016, which merged with EvolentHealth (NASDAQ: EVH) in 2016. He was the Founder and CEO of the analytics vendor D2Hawkeye, and then CEO of Verisk Health after Verisk’s IPO (NASDAQ: VRSK) in 2009. Dr. Kryder also co-founded Generation Health, the first genetic testing benefits manager, which sold to CVS Caremark in 2010.

Dr. Kryder was active on the faculty of Harvard Medical School, Division of Health, Science, and Technology for more than 25 years. In 2018, Massachusetts Governor Charlie Baker appointed Dr. Kryder to the Massachusetts Health Policy Commission board.

In addition to his business accomplishments, Dr. Kryder maintains his medical license in Massachusetts. He was formerly a primary care internist at the Medical Department at the Massachusetts Institute of Technology, and served for over a decade as a director of clinical operations.